# V1 Empirics Check — moonshotai/kimi-k2.5 (Variant B)

**Model:** moonshotai/kimi-k2.5
**Variant:** B
**Date:** 2026-03-27T14:44:53.762468

---

 **Referee Report**

**Paper:** "The Destigmatization Dividend: Conversion Therapy Bans and Adolescent Mental Health"  
**Authors:** APEP Autonomous Research  
**Journal:** AER: Insights (submission format)

---

### 1. Idea Fidelity

The paper pursues the core idea from the manifest—estimating the causal effect of conversion therapy bans on adolescent mental health using staggered state adoption and YRBSS data—but deviates in ways that substantively weaken the identification strategy and scope. 

**Key deviations:**
- **Estimator choice**: The manifest specified Callaway-Sant'Anna (2021) as the primary identification strategy; the paper instead uses two-way fixed effects (TWFE) as the main specification and relegates CS to a robustness check. This is consequential because the CS estimates yield much smaller, statistically insignificant effects (-0.94 pp vs. -2.8 pp for persistent sadness) that undermine the paper's central claims.
- **Triple-difference limitations**: The manifest promised a triple-difference comparing LGB vs. heterosexual youth within treated vs. control states. However, because the sexual identity question was only asked in 2021–2023, the heterogeneity analysis relies on cross-sectional variation (comparing LGB youth in ban states to LGB youth in non-ban states) rather than within-state changes over time. This is not a triple-difference design but a cross-sectional difference-in-differences, confounding the "targeted population" test with persistent state-level differences in LGB acceptance.
- **Missing controls**: The manifest included state political composition, other LGBTQ+ laws, and Medicaid expansion as controls; the paper includes only individual-level demographics (sex, race, grade), omitting time-varying state-level confounders that likely correlate with ban adoption.
- **Reduced treatment variation**: The manifest promised 24 treatment states; the paper delivers only 14 states with bans appearing in the YRBSS sample (of 39 total states). This substantially limits external validity and power.

---

### 2. Summary

This paper estimates the effect of state-level conversion therapy bans on adolescent mental health using five waves of the YRBSS (2015–2023). The authors find that bans reduce population-level persistent sadness and suicide planning, with larger effects concentrated among LGB-identified youth in cross-sectional analyses from 2021–2023. The results are interpreted as evidence of a "destigmatization dividend" from legislative signaling.

---

### 3. Essential Points

The paper makes a valuable contribution by expanding the treatment variation beyond prior work, but three critical issues must be addressed to sustain causal claims:

**1. The "triple-difference" is actually a cross-sectional comparison that cannot rule out state-level confounders.**  
Because sexual identity was only measured in 2021 and 2023, the interaction analysis (Table 3) compares LGB youth in ban states to LGB youth in non-ban states, absorbing all time-invariant state characteristics that differ between treatment and control groups (e.g., baseline social acceptance of LGBTQ+ individuals, pre-existing school climate policies). The paper acknowledges this limitation briefly but downplays its severity. To convincingly identify targeted effects, you need either (a) pre-2021 sexual identity data to exploit the staggered timing, or (b) a convincing argument that the 2021–2023 cross-section is as-if random conditional on controls. Currently, the concentration of effects among LGB youth could simply reflect that progressive states adopted bans *and* have better mental health environments for sexual minorities unrelated to the ban itself.

**2. Omitted state-level time-varying covariates threaten parallel trends.**  
Conversion therapy bans were typically adopted as part of bundles of progressive LGBTQ+ legislation (anti-discrimination laws, hate crime protections, bathroom access laws) and during periods of Democratic legislative control. Without controlling for these concurrent policies or state-level political composition, the DiD estimator conflates the effect of conversion therapy bans with the broader policy environment. The inclusion of state fixed effects does not address this because these covariates vary within states over time (e.g., Colorado adopted a ban in 2019 alongside other expansions of LGBTQ+ rights). The manifest promised controls for "state political composition, other LGBTQ+ laws, Medicaid expansion"—these must be included.

**3. Early adopters lack pre-treatment data, and inference with 39 states is fragile.**  
California (2012) and New Jersey (2013) enacted bans before the first YRBSS wave in the sample (2015). Including these states as treated units without pre-treatment observations violates the parallel trends assumption (which requires pre-periods for all treated units) and risks "asynchronous" DiD bias. While you drop them in robustness, the baseline estimates rely heavily on these units. Furthermore, with only 39 states and clustering at the state level (14 treated), standard errors are likely underestimated. The CS estimator's insignificant results may reflect more appropriate handling of this variation than a failure of the research design.

---

### 4. Suggestions

**Identification and Estimation:**
- **Address the aggregation mismatch in the heterogeneity analysis.** If sexual identity data are truly unavailable before 2021, frame the LGB analysis explicitly as a cross-sectional comparison and employ methods to strengthen causal interpretation: include state-level measures of baseline LGBTQ+ acceptance (e.g., pre-2012 attitudes from the American Values Survey), other contemporaneous state policies (same-sex marriage legalization timing, anti-bullying laws with LGBTQ+ protections, transgender healthcare access), and state-by-year economic conditions. Alternatively, if partial sexual identity data exist for 2015–2019 in some states (the manifest suggests the question was included in ~30 states by 2021), use an imputation strategy or multiple datasets (e.g., the Center for Disease Control's Middle School YRBSS or state-specific surveys) to recover pre-treatment LGB-specific trends.
- **Report event-study plots** for the main TWFE specification to visualize pre-trends and dynamic treatment effects. If California and New Jersey drive the results due to their early timing (as suggested by your leave-one-out exercise showing attenuation when California is dropped), consider a synthetic control approach for these early adopters or exclude them entirely from the baseline sample.
- **Reconcile the CS and TWFE results.** The CS estimates are roughly one-third the magnitude of TWFE and insignificant. This discrepancy suggests the TWFE results may be driven by heterogeneous treatment effects across timing groups (early vs. late adopters). Present decompositions using Sun and Abraham (2021) or stacked regression estimators to show where the TWFE weights are coming from.

**Data and Measurement:**
- **Clarify the external validity of the YRBSS sample.** Only 39 states appear in the analysis, and only 14 have bans. Which states are missing? If the missing states are systematically different (e.g., smaller, more conservative, lower LGBTQ+ population), this limits generalizability. Provide a table comparing observable characteristics of YRBSS-participating states vs. non-participating states.
- **Address substance use.** The manifest promised substance use as an outcome; the paper omits it without explanation. If data constraints prevented its inclusion, state this explicitly. If not, include it as a falsification test—substance use should theoretically respond to destigmatization but less directly than suicidality.
- **Use wild cluster bootstrap** or similar methods given the small number of clusters (39 states). Standard clustered variance estimators rely on asymptotic approximations that perform poorly with fewer than 50 clusters and can severely understate standard errors.

**Interpretation and Mechanisms:**
- **Distinguish "conversion therapy ban effects" from "progressive policy bundle effects."** The mechanism section suggests a destigmatization dividend, but this could operate through any LGBTQ+-affirming policy, not specifically conversion therapy bans. Test for dosage effects: do states with stronger bans (covering religious counselors, including gender identity, criminal penalties vs. professional discipline) show larger effects? This would sharpen the mechanism.
- **Investigate the timing.** If the mechanism is normative signaling, effects should appear immediately after enactment (or even in anticipation). If effects accumulate gradually, this suggests a direct pipeline mechanism (fewer youth undergoing therapy over time). Plot leads and lags around the ban date to distinguish these.
- **Consider spillovers.** If destigmatization operates through social norms, untreated states bordering treated states might show partial effects (spatial spillovers). This would bias your estimates toward zero but could explain the small CS estimates if spillovers are large.

**Presentation:**
- **Standardize the cohort definitions.** The text mentions 22 states but Table 1 reports 14 treated states. Clarify that 22 states enacted bans by 2023, but only 14 appear in the YRBSS sample during the treatment period. Discuss whether the excluded states differ systematically.
- **Report pre-treatment means by treatment group** (not just pooled means) to assess baseline differences that might drive the DiD results.

**Minor:**
- The paper mentions "Medicaid expansion" as a control in the manifest but not the paper. Include it or explain its exclusion, as Medicaid expansion timing correlates with both progressive legislative environments and youth mental health access.

Overall
